As diabetes care continues to be a significant focus, new treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy advancement in GLP-1 receptor agonist medications. While all work to enhance glucose management and facilitate reduction in body fat, their approac